Immunome Inc (IMNM)

Finanzdaten der Immunome Inc-Aktie (IMNM)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	4.02
	31.69%78.14	59.33	72.86	60.14	50.49
Research and Development	29.12%59.89	46.38	50.77	49.19	40.45
Operating Income/Loss	31.69%-78.14	-59.33	-72.86	-60.14	-46.48
Net Interest Income/Expense	8.81%5.01	5.49	2.96	2.68	3.08
	35.83%-73.13	-53.84	-69.90	-57.46	-43.40
Attributable To Parent	35.83%-73.13	-53.84	-69.90	-57.46	-43.40
Available To Common Stockholders, Basic	35.83%-73.13	-53.84	-69.90	-57.46	-43.40
Basic Average Shares	0.12%113.27	113.14	2.53	87.96	87.01
Diluted Average Shares	0.12%113.27	113.14	2.53	87.96	87.01
Basic Earnings Per Share	35.42%-0.65	-0.48	-0.75	-0.65	-0.50
Diluted Earnings Per Share	35.42%-0.65	-0.48	-0.75	-0.65	-0.50